Fenwick's life sciences practice co-chair and intellectual property partner Michael Shuster and corporate partner Matthew Rossiter talked to Above the Law about the firm’s recognition as one of the top life sciences deal firms by Lake Whillans.
Shuster and Rossiter credit Fenwick’s collaborative culture for its success.
“As a group and as a firm, by culture and how we designed and organized ourselves internally, we do a very good job of collaborating,” Rossiter said. “I work with and talk to Michael regularly. He’s a patent lawyer and I’m a corporate lawyer, and we talk with each other and coordinate. For deals, particularly in a complex space like life sciences, that ability to collaborate is critical."
The partners also discussed the current market for life sciences companies, and how diverse Fenwick lawyers collaborate to best meet their clients' needs.
“We’re seeing informatics components in a lot of our clients,” Shuster told Above the Law. “PACT Pharma is a new client of ours. They are working on T-cell receptors; large informatics component there. We’re seeing heavy application of informatics (including machine learning) technologies by companies that are in the diagnostic space, as well. We’re creating teams that pair members from the life sciences and high-tech sides of our patent practice to bring deep and sophisticated expertise to support these efforts.”
The full article is available through the Above the Law website.